EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer

Abstract

Higher pre-treatment CTC counts are a negative independent prognostic factor in SCLC when considered as a continuous variable or dichotomised counts of ≥15 or ≥50. Incorporating CTC counts, as a continuous variable, improves clinic-pathological prognostic models.